| site address | dk.linkedin.com/company/genmab?trk=organization_guest_main-feed-card_feed-actor-image |
| site title | Genmab | LinkedIn |
| status of last verification |  - no comments
|
| site size & charset | 314698; utf-8; |
| meta description | Genmab 179.215 følgere på LinkedIn. We are an international biotechnology company dedicated to improving the lives of people with cancer and other serious diseases through innovative antibody medicines. Long recognized for our expertise in antibody innovation, our passionate and collaborative team has pioneered antibody-based formats, including bispecific antibodies, antibody-drug conjugates, immune-modulating antibodies, and other modalities for the treatment of cancer and other serious diseases.
Today, we are advancing a strong late-stage clinical pipeline, including wholly owned programs, with the goal of delivering transformative medicines to patients. |
| meta keywords | |
| hashtags | |
| website verified | |
| |
|
|
|
| site address | de.linkedin.com/company/genmab |
| site title | Genmab | LinkedIn |
| status of last verification | - no comments
|
| site size & charset | 37066; utf-8; |
| meta description | Genmab 178.003 Follower:innen auf LinkedIn. We are an international biotechnology company dedicated to improving the lives of people with cancer and other serious diseases through innovative antibody medicines. Long recognized for our expertise in antibody innovation, our passionate and collaborative team has pioneered antibody-based formats, including bispecific antibodies, antibody-drug conjugates, immune-modulating antibodies, and other modalities for the treatment of cancer and other serious diseases.
Today, we are advancing a strong late-stage clinical pipeline, including wholly owned programs, with the goal of delivering transformative medicines to patients. |
| meta keywords | |
| hashtags | |
| website verified | |
| |
|
|
|
